News
While upholding the right to fair trial of an accused, the Indore Bench of Madhya Pradesh High Court said that denial of ...
State of Survival’s latest crossover brings IO Interactive’s formidable Hitman into the undead-slaying iPhone and Android ...
Coagulation Station, the itch.io horror game that has you maintaining a blood mine, is getting a full-blown Steam sequel. Dubbed Coagulation Station: Fleshfall, this first-person outing promises to be ...
11h
NDTV Profit on MSNSEBI Plans To Relax Proposed Limits On Index Options TradingSources indicated that SEBI is leaning towards allowing a net end of the day limit of Rs 1,500 crore and a gross limit of Rs ...
Not everyone in crypto wants to be seen. As 2025 rolls on, the digital asset space is undergoing a quiet transformation. While mainstream exchanges chase regulation, fiat integration, and Wall Street ...
14h
India Today on MSNGoogle IO 2025 to kick off on May 20: Android 16, Gemini and more to expectGoogle I/O 2025 -- is confirmed to kick off on May 20. Without revealing the intricate details, the tech giant has indicated ...
Dog Days for free on VPesports! This way you can join the adventure with our guide for easy access via Steam. Enjoy the ...
The Southern Heritage Air Foundation (SHAF) has announced its collaboration with NASA ASTRO CAMP®. “Our very first camp ...
Gate.io's latest Proof of Reserves report reveals $10.865B in total reserves, 128.6% reserve ratio, using zero-knowledge ...
When working remotely on broadcast and live event content, network predictability can be uncertain, introducing ... Read More ...
Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.
Compass Therapeutics, Inc.’s CMPX share price has dipped by 5.62%, which has investors questioning if this is right time to buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results